This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Cacioppo CN , Egleston BL , Fetzer D , Burke Sands C , Raza SA , Reddy Malleda N , McCarty Wood E , Rittenburg I , Childs J , Cho D , Hosford M , Khair T , Khatri J , Komarnicky L , Poretta T , Rahman F , Shah S , Patrick-Miller LJ , Domchek SM , Bradbury AR
Randomized study of remote telehealth genetic services versus usual care in oncology practices without genetic counselors
Cancer Med. 2021 Jul;10(13) :4532-4541
PMID: 34102012 PMCID: PMC8267134 URL: https://www.ncbi.nlm.nih.gov/pubmed/34102012
AbstractPURPOSE: To examine the benefit of telehealth over current delivery options in oncology practices without genetic counselors. METHODS: Participants meeting cancer genetic testing guidelines were recruited to this multi-center, randomized trial comparing uptake of genetic services with remote services (telephone or videoconference) to usual care in six predominantly community practices without genetic counselors. The primary outcome was the composite uptake of genetic counseling or testing. Secondary outcomes compare telephone versus videoconference services. RESULTS: 147 participants enrolled and 119 were randomized. Eighty percent of participants in the telehealth arm had genetic services as compared to 16% in the usual care arm (OR 30.52, p < 0.001). Five genetic mutation carriers (6.7%) were identified in the telehealth arm, compared to none in the usual care arm. In secondary analyses, factors associated with uptake were lower anxiety (6.77 vs. 8.07, p = 0.04) and lower depression (3.38 vs. 5.06, p = 0.04) among those who had genetic services. There were no significant differences in change in cognitive or affective outcomes immediately post-counseling and at 6 and 12 months between telephone and videoconference arms. CONCLUSION: Telehealth increases uptake of genetic counseling and testing at oncology practices without genetic counselors and could significantly improve identification of genetic carriers and cancer prevention outcomes.
Notes2045-7634 Cacioppo, Cara N Orcid: 0000-0003-4761-7027 Egleston, Brian L Orcid: 0000-0002-1633-799x Fetzer, Dominique Burke Sands, Colleen Raza, Syeda A Reddy Malleda, Neeraja McCarty Wood, Elisabeth Rittenburg, India Childs, Julianne Cho, David Hosford, Martha Khair, Tina Khatri, Jamil Komarnicky, Lydia Poretta, Trina Rahman, Fahd Shah, Satish Patrick-Miller, Linda J Domchek, Susan M Bradbury, Angela R Basser Center/ Journal Article United States Cancer Med. 2021 Jun 8. doi: 10.1002/cam4.3968.